B. Feng, Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma.I nNasopharyngeal carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.23-41

X. Cai, A. Schafer, S. Lu, J. Bilello, R. Desrosiers et al., Epstein???Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed, PLoS Pathogens, vol.10, issue.3, p.23, 2006.
DOI : 10.1371/journal.ppat.0020023.sg006

R. Edwards, A. Marquitz, and N. Raab-traub, Epstein-Barr Virus BART MicroRNAs Are Produced from a Large Intron prior to Splicing, Journal of Virology, vol.82, issue.18, pp.9094-9106, 2008.
DOI : 10.1128/JVI.00785-08

K. Cosmopoulos, M. Pegtel, J. Hawkins, H. Moffett, C. Novina et al., Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma, Journal of Virology, vol.83, issue.5, pp.2357-2367, 2009.
DOI : 10.1128/JVI.02104-08

J. Zhu, T. Pfuhl, N. Motsch, S. Barth, J. Nicholls et al., Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas, Journal of Virology, vol.83, issue.7, pp.3333-3341, 2009.
DOI : 10.1128/JVI.01689-08

C. Gourzones, A. Gelin, I. Bombik, J. Klibi, B. Verillaud et al., Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells, Virology Journal, vol.7, issue.1, p.271, 2010.
DOI : 10.1186/1743-422X-7-271

A. Wong, K. Kong, J. Tsang, D. Kwong, and X. Guan, Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs, Cancer, vol.317, issue.pt 19, pp.698-710, 2012.
DOI : 10.1002/cncr.26309

P. Mitchell, R. Parkin, E. Kroh, B. Fritz, S. Wyman et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.105, issue.30, pp.10513-10518, 2008.
DOI : 10.1073/pnas.0804549105

P. Lesnik, A. Vonica, M. Guerin, M. Moreau, and M. Chapman, Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a) Arteriosclerosis and thrombosis: a journal of vascular biology, pp.1066-1075, 1993.

K. Vickers, B. Palmisano, B. Shoucri, R. Shamburek, and A. Remaley, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature Cell Biology, vol.257, issue.4, pp.423-433, 2011.
DOI : 10.1073/pnas.011404098

M. Cortez, C. Bueso-ramos, J. Ferdin, G. Lopez-berestein, A. Sood et al., MicroRNAs in body fluids???the mix of hormones and biomarkers, Nature Reviews Clinical Oncology, vol.135, issue.8, pp.467-477, 2011.
DOI : 10.1038/nrclinonc.2011.76

N. Healy, H. Heneghan, N. Miller, C. Osborne, R. Schiff et al., Systemic mirnas as potential biomarkers for malignancy, International Journal of Cancer, vol.14, issue.Suppl 1, pp.2215-2222, 2012.
DOI : 10.1002/ijc.27642

M. Cortez, J. Welsh, and G. Calin, Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer, pp.151-161, 2012.

J. Arroyo, J. Chevillet, E. Kroh, I. Ruf, C. Pritchard et al., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences, vol.108, issue.12, pp.5003-5008, 2011.
DOI : 10.1073/pnas.1019055108

A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, Characterization of extracellular circulating microRNA, Nucleic Acids Research, vol.39, issue.16, pp.7223-7233, 2011.
DOI : 10.1093/nar/gkr254

C. Gourzones, P. Busson, and N. Raab-traub, Epstein-Barr Virus and the Pathogenesis of Nasopharyngeal CarcinomasInNasopharyngeal Carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.42-60

Z. Pratt, M. Kuzembayeva, S. Sengupta, and B. Sugden, The microRNAs of Epstein???Barr Virus are expressed at dramatically differing levels among cell lines, Virology, vol.386, issue.2, pp.387-397, 2009.
DOI : 10.1016/j.virol.2009.01.006

V. Hadinoto, M. Shapiro, C. Sun, and D. Thorley-lawson, The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output, PLoS Pathogens, vol.82, issue.7, p.1000496, 2009.
DOI : 10.1371/journal.ppat.1000496.s008

K. Wang, Y. Yuan, J. Cho, S. Mcclarty, D. Baxter et al., Comparing the MicroRNA Spectrum between Serum and Plasma, PLoS ONE, vol.7, issue.7, p.41561, 2012.
DOI : 10.1371/journal.pone.0041561.s007

C. Gourzones, A. Jimenez, and P. Busson, Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs, Cancer, vol.118, issue.18, pp.4634-4634, 2012.
DOI : 10.1002/cncr.26514

D. Meckes, . Jr, K. Shair, A. Marquitz, C. Kung et al., Human tumor virus utilizes exosomes for intercellular communication, Proceedings of the National Academy of Sciences, vol.107, issue.47, pp.20370-20375, 2010.
DOI : 10.1073/pnas.1014194107

S. Bala, J. Petrasek, S. Mundkur, D. Catalano, I. Levin et al., Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases, Hepatology, vol.2, issue.5, pp.1946-57, 2012.
DOI : 10.1002/hep.25873

J. Chan, W. Gao, W. Ho, W. Wei, and T. Wong, Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma, Anticancer Res, vol.32, pp.3201-3210, 2012.

A. Chan and E. Felip, Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

J. Nicholls and G. Niedobitek, Histopathological diagnosis of nasopharyngeal carcinoma -Looking beyond the blue bookInNasopharyngeal carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.10-22

C. Gourzones, F. Ferrand, B. Vérillaud, and P. Busson, Biological tools for NPC population screening and disease monitoring.I nNasopharyngeal Carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.101-117

S. Charrin, L. Naour, F. Oualid, M. Billard, M. Faure et al., The major CD9 and CD81 molecular partner. Identification and characterization of the complexes, J Biol Chem, vol.276, pp.14329-14337, 2001.

A. Dehee, C. Asselot, T. Piolot, C. Jacomet, W. Rozenbaum et al., Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR, Journal of Medical Virology, vol.78, issue.3, pp.543-552, 2001.
DOI : 10.1002/jmv.2071

E. Kroh, R. Parkin, P. Mitchell, and M. Tewari, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, vol.50, issue.4, pp.298-301, 2010.
DOI : 10.1016/j.ymeth.2010.01.032

. Gourzones, Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport, Virology Journal, vol.10, issue.1, p.119, 2013.
DOI : 10.1016/j.ymeth.2010.01.032

URL : https://hal.archives-ouvertes.fr/inserm-00835488